Prevalence of anti-tissue transglutaminase antibodies in patients with irritable bowel syndrome in Duhok city / Prevalência de anticorpos antitransglutaminase tecidual em pacientes com síndrome do intestino irritável na cidade de Duhok

Abstract Background Irritable bowel syndrome (IBS) is a common gastrointestinal disorder; celiac disease is an autoimmune enteropathy that can mimic any functional gastrointestinal disorder. The aim of this study is to estimate the prevalence of celiac disease antibodies (anti Tissue Transglutaminase-tTG) in patients with irritable bowel syndrome. Patients and methods This cross sectional study was conducted on 70 patients with irritable bowel syndrome fulfilling Rome III criteria who visited Azadi Teaching Hospital in Duhok city-Iraq. Patients were classified according to irritable bowel syndrome subtypes into: Diarrhoea Predominant (D-IBS), Constipation Predominant (C-IBS) and Mixed (M-IBS). IgA and IgG anti tTG were used to screen patients for celiac disease. Results A total number of 70 patients (44 females and 26 males) were included; their mean age was 33 years (SD ± 7.64). Five patients (7.1%) were found to have positive both IgA and IgG anti tTG. Three of them have had D-IBS and the other two had C-IBS. No one of the M-IBS patients tested positive. Conclusion The prevalence of anti tTG antibodies in irritable bowel syndrome is high. Patients with D-IBS should be screened for celiac disease.

Resumo Introdução A síndrome do intestino irritável (SII) é um distúrbio gastrointestinal comum; a doença celíaca é uma enteropatia autoimune que pode imitar qualquer distúrbio gastrointestinal funcional. O objetivo deste estudo foi estimar a prevalência de anticorpos contra a doença celíaca (antitransglutaminase tecidual - tTG) em pacientes com SII. Pacientes e Métodos Este estudo transversal foi conduzido em 70 pacientes com síndrome do intestino irritável que atendiam aos critérios de Roma III e se apresentaram ao Hospital de Ensino Azadi na cidade de Duhok, no Iraque. Os pacientes foram classificados de acordo com os subtipos de síndrome do intestino irritável em: predominantemente diarreia (D-SII), predominantemente constipação (C-SII) e mista (M-SII). IgA e IgG antitTG foram usados para rastrear pacientes com doença celíaca. Resultados Um total de 70 pacientes (44 mulheres e 26 homens) foram incluídos; a idade média foi de 33 anos (DP ± 7,64). Cinco pacientes (7,1%) apresentaram IgA e IgG antitTG positivos. Três deles tinham D-SII e os outros dois tinham C-SII. Nenhum dos pacientes com M-SII apresentou teste positivo. Conclusão A prevalência de anticorpos antitTG na SII é alta. A presença de doença celíaca deve ser avaliada em pacientes com D-SII.

Quality of life in patients with different constipation subtypes based on the Rome III criteria.

BACKGROUND: Functional constipation and irritable bowel syndrome with constipation are highly prevalent and affect the quality of life of those who suffer from them. AIMS: To evaluate quality of life in patients with functional constipation and irritable bowel disease in accordance with the Rome III criteria, using the PAC-QOL and SF-36 questionnaires. MATERIALS AND METHODS: A cross-sectional study was conducted using self-administered questionnaires. The PAC-QOL, SF-36, and Rome III constipation module questionnaires were applied to patients that complained of constipation at the outpatient clinic of a tertiary care hospital. The constipation subtypes were: functional constipation (no pain), irritable bowel syndrome with constipation (pain and/or discomfort ≥3 days/month), and unclassifiable constipation (pain ≤2 days/month). Data were summarized in proportions, and group comparisons were made between the scores of each of the areas of the PAC-QOL and SF-36 questionnaires using parametric tests (Student's t test and ANOVA). RESULTS: A total of 43 PAC-QOL surveys were analyzed, resulting in cases of irritable bowel syndrome with constipation (14%), functional constipation (37%), and unclassifiable constipation (49%). There were statistically significant differences (P<.05) in Physical discomfort (irritable bowel syndrome with constipation vs. functional constipation and unclassifiable constipation vs. irritable bowel syndrome with constipation), Worries and concerns (irritable bowel syndrome with constipation vs. functional constipation), and Treatment satisfaction (irritable bowel syndrome with constipation vs. functional constipation and unclassifiable constipation vs. irritable bowel syndrome with constipation). A total of 93 SF-36 questionnaires were analyzed, describing cases of irritable bowel syndrome with constipation (23%), functional constipation (27%), and unclassifiable constipation (51%). Lower physical energy was found in relation to irritable bowel syndrome with constipation vs. functional constipation (P<.0221) and unclassifiable constipation (P<.0086), respectively, and there was greater physical pain in the cases of irritable bowel syndrome with constipation vs. unclassifiable constipation (P<.0362). CONCLUSIONS: Differences in quality of life of patients presenting with constipation subtypes were identified using the PAC-QOL and SF-36 questionnaires. The patients that had the irritable bowel syndrome with constipation subtype experienced poorer quality of life in all the evaluated domains.

Chronic idiopathic anal pain. Results of a diagnostic-therapeutic protocol in a colorectal referral unit.

INTRODUCTION: Chronic idiopathic anal pain (CIAP) remains a diagnosis of exclusion. Its study and management still lack a standardized protocol. The aim of this study is to evaluate the results obtained with the diagnostic-therapeutic protocol established in our service. MATERIAL AND METHODS: We performed a retrospective study of patients diagnosed with CIAP at the Colorectal Unit of the General University Hospital of Elche, between 2005 and 2011. RESULTS: We evaluated 57 patients with a diagnosis of chronic anal pain for functional anorectal disease (FAD). After the application of our diagnostic protocol, final diagnosis of chronic anal pain (CAP) was achieved in 43 cases (75%), including 22 cases of descending perineum syndrome, 12 of proctalgia fugax, 2 of pudendal neuritis and 7 of coccydynia. In 14 patients exclusion diagnosis of CIAP was established. Among the therapies used on patients with CIAP, biofeedback combined with conservative measures improved symptoms in 43% of the cases. Sacral nerve stimulation was assessed in patients who did not respond to other treatments. CONCLUSION: Through proper anamnesis, physical examination and complementary tests, a specific diagnosis of the cause of CAP by FAD can be achieved, reducing exclusion diagnosis of CIAP to 25% of cases. Conservative measures combined with biofeedback achieved an improvement in pain in more than 40% of the cases of CIAP in our study. Sacral nerve stimulation can be considered as a treatment option in refractory cases.

Avaliação topográfica do cólon transverso pelo enema opaco: definição, prevalência e proposta de classificação da ptose do cólon transverso / Topographic evaluation of the transverse colon by barium enema: definition, prevalence and proposed of a classification of the enteroptosis

Objetivo: a ptose do cólon foi definida em 1922 por Cannon como rebaixamento do segmento transverso, em forma de V, podendo estender-se até o nível pélvico, sendo que quanto mais agudos forem os ângulos das flexuras esplênica e hepática, maior será a gravidade da sintomatologia, que inclui flatulência, distensão abdominal e constipação. Embora seja consenso na prática clínica que a enteroptose seja detectada frequentemente nos enemas opacos, ainda não há unanimidade na sua definição conceitual, além da inexistência de dados sobre sua prevalência. A possível relação entre esta alteração patológica e a constipação intestinal torna ainda mais relevante e instigante o seu estudo. Objetivo: definir e estabelecer a prevalência em nosso meio, e propor uma classificação radiológica para a enteroptose. Método: este estudo foi realizado em duas etapas. Na primeira foram analisados 193 enemas opacos digitais, visando estabelecer a prevalência da ptose. E a segunda propôs uma classificação topográfica em graus (0, 1 e 2), sendo a de Grau 2 considerada como a enteroptose verdadeira. Resultados: a prevalência de enteroptose verdadeira foi de 35 (18%) dos 193 enemas opacos examinados, sendo estatisticamente mais prevalente em mulheres (p=0,039). Considerando a prevalência mundial da constipação de até 20%, é plausível supor que possa haver correlação entre constipação e ptose Grau 2. Conclusão: não há na literatura mundial estudos sobre prevalência ou classificação da ptose do transverso, e acreditamos que a presente classificação em graus, associada à avaliação sintomatológica baseada nos critérios de Roma III, será um grande norteador para indicar a conduta diagnóstica na constipação.

Introduction: the enteroptosis was defined in 1922 by Cannon as flattening of the transverse segment, in V form, extending to the pelvic level, and if more acute are the angles of splenic and liver flexures, greater will be the symptom including flatulence, bloating and constipation. Although consensus in clinical practice often detected enteroptosis in barium enemas, there is no unanimity in the conceptual definition, besides there is no data about the prevalence. The possible relationship between this pathological change and constipation becomes this study even more relevant and compelling. Objective: define, establish the prevalence in our environment and propose a radiological classification for enteroptosis. Method: this study was conducted in two phases. In the first 193 digital barium enemas were analyzed to establish the prevalence of eneroptosis. The second proposed a topographic classification in degrees (0. 1 and 2), being considered Degree 2 as the true enteroptosis. Results: the prevalence of true enteroptosis was 35 (18 %) of the 193 examined barium enemas, being statistically more prevalent in women (p=0.039). Given the global prevalence of constipation up to 20% it is plausible that there may be a correlation between constipation and enteroptosis Degree 2. Conclusion: there are no studies in the literature about the prevalence or classification of enteroptosis, and we believe that the present classification in degrees, associated with the symptomatology assessment based in Rome III criteria will be a great guiding to indicate the diagnostic of constipation.

Constipation prevalence in diabetic patients / Frequência da constipação intestinal em pacientes diabéticos

OBJECTIVE: the aim of this study was to identify the prevalence of constipation in diabetic patients treated at the endocrinology outpatient clinic at Hospital Universitário Professor Alberto Antunes and PAM Salgadinho, from April to August 2013. METHODS: a descriptive and cross-sectional study, carried out through a questionnaire using the Rome III criteria in 372 patients treated at the outpatient endocrinology clinic. RESULTS: of 372 patients evaluated, the frequency of constipation found was 31.2% among diabetic patients. Females predominated in the sample (72.8%) as well as for the frequency of constipation (80.2%). The incidence of type II diabetes was 97.3% and it was observed that 80.2% of the sample was older than 50 years. One hundred and twelve patients with inadequate glycemic control (HgA1c = 7) had an association with constipation. CONCLUSION: there was an increased frequency of constipation in patients with diabetes mellitus according to the Rome III criteria, in relation to the general population. The inadequate glycemic control in patients with diabetes mellitus increases the frequency of constipation and it is necessary to perform studies that allow the confirmation of this association to demonstrate this hypothesis. (AU)

OBJETIVO: analisar a prevalência da constipação intestinal em pacientes diabéticos atendidos no ambulatório de endocrinologia do Hospital Universitário Professor Alberto Antunes e no PAM Salgadinho (HUPAA), de abril de 2013 a agosto 2013. MÉTODO: estudo descritivo e transversal, realizado através da aplicação de um questionário com os critérios de Roma III no ambulatório de endocrinologia do HUPAA. RESULTADO: em 372 pacientes, 271 feminino, 101 masculino, 162 de etnia branca, 55 negros e 155 pardos, 297 pacientes estavam acima de 50 anos, houve uma frequência de constipação de 31,2% nos pacientes diabéticos. O gênero feminino prevaleceu na amostra (73%) assim como no índice de frequência da constipação (80,2%). Em nossa amostra a diabetes Tipo II foi verificada em 360 pacientes (97%) e o tipo 1 em 12 pacientes (3%), observou-se que 80% da amostra apresentavam idade superior a 50 anos. Em 112 pacientes com controle glicêmico inadequado (HgA1c =7) havia uma associação com a constipação intestinal. CONCLUSÃO: encontramos maior frequência da constipação intestinal em pacientes com Diabetes Mellitus, segundo os critérios de Roma III, em relação à população geral. Há uma associação entre o controle glicêmico inadequado nos pacientes com Diabetes Mellitus e a frequência da constipação, faz-se necessário a realização de outros estudos que possibilitem confirmar a associação dessa varíavel para comprovação desta hipótese. (AU)

Disfunción del esfínter de Oddi y pancreatitis idiopática / Sphincter of Oddi dysfunction (SOD) and idiopatic pancreatitis

The sphincter of Oddi dysfunction is a little known entity that typically occurs in post-cholecystectomy patients with abdominal pain with biliary or pancreatic characteristics. It represents an important cause of idiopathic recurrent acute pancreatitis. Most of the patients referred for sphincter of Oddi dysfunction study have another disease which explain the symptoms, so a careful history and appropriate physical examination often can identify the true source of the pain. The most used grading score is the Milwaukee classification, based on clinical, laboratory, imaging and cholangiographic findings. In the last decade, new and more applicable criteria have been developed, such as Rome III criteria, which do not require functional tests considered complex and not available in non-specialized centers. The sphincter of Oddimanometry is considered the gold standard for the diagnosis of this entity, allowing for the determination of which patients will benefit from endoscopic therapy (sphincterotomy). There are some noninvasive diagnostic tests that have failed to show strong correlation to displace the sphincter of Oddi. The treatment of this condition is mainly based on endoscopic sphincterotomy, with variable success rates depending on the type of dysfunction. This article presents a review of the most important aspects related to the sphincter of Oddi and its relationship with idiopathic recurrent pancreatitis.

La disfunción del esfínter de Oddi es una entidad poco conocida, que típicamente se presenta en pacientes post-colecistectomía con dolor abdominal de tipo “biliar” o “pancreático”. Representa unaimportante causa de pancreatitis aguda recurrente idiopática. La mayoría de los pacientes derivados para estudio de disfunción del esfínter de Oddi corresponden a otra causa o enfermedad que explica los síntomas, por lo que una cuidadosa historia clínica y un adecuado examen físico, a menudo permiten identificar el verdadero origen del cuadro doloroso. La clasificación más utilizada es la de Milwaukee basada en parámetros clínicos, de laboratorio, imagenológicos y colangiográficos. En la última década, se han elaborado criterios de mayor aplicabilidad clínica como los criterios de Roma III, que no requieren de test funcionales considerados complejos y poco disponibles en centros no especializados. La manometría del esfínter de Oddi es considerado el gold standard en el diagnóstico de esta entidad, permitiendo además, establecer quiénes se beneficiarán con la terapia endoscópica (esfinterotomía). Se han desarrollado una serie de otros métodos diagnósticos no invasivos, que no han logrado demostrar una correlación suficientemente sólida para desplazar a la manometría. El tratamiento de esta condición se basa principalmente en la esfinterotomía endoscópica, con una tasa de éxito variable dependiendo del tipo de disfunción. En el presente artículo se revisarán los aspectos más importantes relacionados con la disfunción del esfínter de Oddi y su relación con pancreatitis recurrente idiopática.

Sensibilidad visceral y dispepsia funcional: o ¿mucho más que eso? / Visceral sensitivity and functional dyspepsia: or much more than this?

La sensibilidad visceral es una respuesta fisiológica normal de las estructuras huecas del tracto alimentario y su alteración (híper o hiposensibilidad) se ha involucrado en la génesis de la mayoría de los trastornos funcionales y su corrección o modulación fundamentan la mayoría de los esfuerzos actuales farmacológicos que buscan la supresión o alivio de síntomas asociados a estas alteraciones. La dispepsia funcional es un trastorno mal entendido fisiopatológicamente, lleno aún de equívocos diagnósticos y sujeto permanente de cambios en su definición, clasificación y enfoque terapéutico.Dada la prevalencia de la entidad parece útil revisar la conceptualización actual de la dispepsia y el papel de la sensibilidad visceral, como el elemento disparador fisiológico de la motilidad, en su fisiopatología.

Visceral sensitivity is a normal physiological response of digestive tract hollow structures. Hypersensitivity and hypo sensitivity have been involved in the genesis of most functional disorders. Currently correction or modulation is usually based on pharmacological efforts which seek to eliminate or alleviate symptoms associated with these disorders. Functional dyspepsia is a poorly understood physiopathological disorder still associated with diagnostic misunderstandings and permanently changing definition, classification and therapeutic approaches. Given the prevalence of this entity it seems useful to review the current conceptualization of dyspepsia and the role of visceral sensitivity as the physiological timer of motility in its physiopathology.

Prevalencia del síndrome de intestino irritable y la relación del estrés laboral con esta patología en los médicos especialistas de dos centros hospitalarios y uno imagenologico de Maracay edo Aragua. Venezuela 2008

El síndrome de intestino irritable (SII) es una entidad clínica crónica, recurrente y común, de difícil diagnóstico, siendo la base diagnóstica la evaluación sintomática. Se ha descrito el estrés emocional como un factor desencadenante de los síntomas que la identifican, pudiéndose presentar con una alta prevalencia en la población joven y laboralmente activa. Objetivos: Determinar la prevalencia del SII, según los Criterios de Roma III, en una población de médicos de tres centros hospitalarios de Maracay. Mayo 2008 y evidenciar la relación del estrés laboral con esta patología. Métodos: A una muestra de 83 médicos especialistas de consultas, aparentemente sanos, del HCM, ASODIAM y HS, escogidos al azar, se les aplicó una encuesta-cuestionario, previo consentimiento verbal individual, interrogando los criterios de Roma III y la Escala de Maslach para medir el estrés laboral. Resultados: Según Roma III la prevalencia del SII en médicos especialistas fue de 37,3% (77,5% femeninos y 22,5% masculinos), de los cuales el 67,7% presentaron estrés laboral. Conclusión: Según el diagnóstico por criterios de Roma III existe una alta prevalencia de SII en la población de médicos especialistas, donde se describe al estrés como posible factor desencadenante de hechos fisiopatológicos que provocan la sintomatología de este síndrome en el grupo estudiado.

Irritable bowel syndrome (IBS) is a clinical chronic entity, recurrent and common; the diagnosis is based on symptomatic diagnostic evaluation. Emotional stress has been described as a trigger for the symptoms; it can be presented with a high prevalence in young population and labor force. Objectives: To determine the prevalence of IBS according to Rome III Criteria in a population of three doctors of hospitals in Maracay, May 2008 and to demonstrate the relationship of work stress with this condition. Methods: A sample of 83 specialists for consultations, apparently healthy of the HCM, and ASODIAM HS, chosen randomly, were interviewed with a questionnaire survey, previous individual verbal consent, using the Rome III Criteria and the Scale of Maslach to measure work stress. Results: According to the Rome III Criteria, the prevalence of IBS in medical specialists was 37.3% (77.5% female and 22.5% male), of which 67.7% had work-related stress. Conclusion: Accordingwith the Rome III Criteria there is a high prevalence of IBS in the physiciansÊ population, which describes stress as a possible trigger for pathophysiological events that cause the symptoms of this syndrome in this study.